Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY).
Chisari CG, Bianco A, Brescia Morra V, Calabrese M, Capone F, Cavalla P, Chiavazza C, Comi C, Danni M, Filippi M, Iaffaldano P, Lanzillo R, Lo Fermo S, Lucisano A, Lugaresi A, Lus G, Marfia GA, Marinelli F, Mirabella M, Moiola L, Perin C, Realmuto S, Toscano S, Trojano M, Vecchio D, Patti F; Italian MS Registry. Chisari CG, et al. Among authors: comi c. Neurotherapeutics. 2023 Oct;20(6):1696-1706. doi: 10.1007/s13311-023-01415-y. Epub 2023 Aug 23. Neurotherapeutics. 2023. PMID: 37610702 Free PMC article.
A novel GRN mutation in an Italian patient with non-fluent variant of primary progressive aphasia at onset: a longitudinal case report.
Castelnovo V, Canu E, Domi T, Pozzi L, Vignaroli F, Spinelli EG, Ghirelli A, Tondo G, Comi C, Riva N, Quattrini A, Carrera P, Filippi M, Agosta F. Castelnovo V, et al. Among authors: comi c. Front Neurosci. 2023 Jun 13;17:1204504. doi: 10.3389/fnins.2023.1204504. eCollection 2023. Front Neurosci. 2023. PMID: 37383099 Free PMC article.
Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study.
Amato MP, Bergamaschi R, Centonze D, Mirabella M, Marfia GA, Totaro R, Lus G, Brescia Morra V, Aguglia U, Comi C, Cavalla P, Zaffaroni M, Rovaris M, Grimaldi LM, Leoni S, Malucchi S, Baldi E, Romano M, Falcini M, Perini P, Assetta M, Portaccio E, Sommacal S, Olivieri N, Parodi F, Todaro DS, Grassivaro N, Farina A, Mondino MM, Filippi M, Trojano M. Amato MP, et al. Among authors: comi c. J Neurol. 2023 Oct;270(10):4687-4696. doi: 10.1007/s00415-023-11820-0. Epub 2023 Jul 5. J Neurol. 2023. PMID: 37405689 Free PMC article.
Real-world use of Safinamide in motor fluctuating Parkinson's disease patients in Italy.
Bovenzi R, Liguori C, Canesi M, D'Amelio M, De Pandis MF, Marini C, Monge A, Padovani A, Tessitore A, Stefani A, Zappia M; SYNAPSES Study Investigators Italian Group. Bovenzi R, et al. Neurol Sci. 2024 Feb;45(2):573-583. doi: 10.1007/s10072-023-07001-6. Epub 2023 Sep 9. Neurol Sci. 2024. PMID: 37684511 Free PMC article.
The PROB-PD trial: a pilot, randomised, placebo-controlled study protocol to evaluate the feasibility and potential efficacy of probiotics in modulating peripheral immunity in subjects with Parkinson's disease.
Martini S, Marino F, Magistrelli L, Contaldi E, Cosentino M, Comi C. Martini S, et al. Among authors: comi c. Pilot Feasibility Stud. 2023 May 8;9(1):77. doi: 10.1186/s40814-023-01306-1. Pilot Feasibility Stud. 2023. PMID: 37158925 Free PMC article.
Gas6/TAM system as potential biomarker for multiple sclerosis prognosis.
D'Onghia D, Colangelo D, Bellan M, Tonello S, Puricelli C, Virgilio E, Apostolo D, Minisini R, Ferreira LL, Sozzi L, Vincenzi F, Cantello R, Comi C, Pirisi M, Vecchio D, Sainaghi PP. D'Onghia D, et al. Among authors: comi c. Front Immunol. 2024 Apr 30;15:1362960. doi: 10.3389/fimmu.2024.1362960. eCollection 2024. Front Immunol. 2024. PMID: 38745659 Free PMC article.
Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson's Disease.
Saponjic J, Mejías R, Nikolovski N, Dragic M, Canak A, Papoutsopoulou S, Gürsoy-Özdemir Y, Fladmark KE, Ntavaroukas P, Bayar Muluk N, Zeljkovic Jovanovic M, Fontán-Lozano Á, Comi C, Marino F. Saponjic J, et al. Among authors: comi c. Int J Mol Sci. 2024 Apr 14;25(8):4330. doi: 10.3390/ijms25084330. Int J Mol Sci. 2024. PMID: 38673915 Free PMC article. Review.
Serum and cerebrospinal fluid neurofilament light chains measured by SIMOA™, Ella™, and Lumipulse™ in multiple sclerosis naïve patients.
Vecchio D, Puricelli C, Malucchi S, Virgilio E, Martire S, Perga S, Passarelli F, Valentino P, Di Sapio A, Cantello R, Dianzani U, Comi C. Vecchio D, et al. Among authors: comi c. Mult Scler Relat Disord. 2024 Feb;82:105412. doi: 10.1016/j.msard.2023.105412. Epub 2023 Dec 26. Mult Scler Relat Disord. 2024. PMID: 38198989 Free article.
177 results